# Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke

> **NCT05105633** · PHASE2,PHASE3 · RECRUITING · sponsor: **University of Melbourne** · enrollment: 688 (estimated)

## Conditions studied

- Basilar Artery Occlusion

## Interventions

- **DRUG:** Tenecteplase
- **DRUG:** Standard Care (which may include intravenous Alteplase)

## Key facts

- **NCT ID:** NCT05105633
- **Lead sponsor:** University of Melbourne
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-29
- **Primary completion:** 2028-05
- **Final completion:** 2029-05
- **Target enrollment:** 688 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05105633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05105633, "Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT05105633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*